Eiko Lifesciences (BOM:540204) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:540204 Eiko Lifesciences Ltd BOM:540204
78 GF Score
Price ₹49.72
GF Value ₹78.58
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Eiko Lifesciences Research & Development?

Eiko Lifesciences BOM:540204 -1.43% 78 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:540204 with a GF Score™ of 78/100 and a GF Value™ of ₹78.58 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Eiko Lifesciences's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Eiko Lifesciences  (BOM:540204) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Eiko Lifesciences Research & Development Related Terms

Eiko Lifesciences Research & Development Historical Data

* Premium members only.

The historical data trend for Eiko Lifesciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eiko Lifesciences Research & Development Chart

Eiko Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Eiko Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:540204
78GF Score
Eiko Lifesciences Ltd BOM:540204
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eiko Lifesciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Eiko Lifesciences (BOM:540204) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Eiko Lifesciences and its competitors.
Is Eiko Lifesciences' Research & Development too high?
Eiko Lifesciences' current Research & Development is ₹0.0 Mil. Overall, Eiko Lifesciences has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eiko Lifesciences' Research & Development compare to LIN and SHW?
Eiko Lifesciences' Research & Development of ₹0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Eiko Lifesciences and its competitors. Eiko Lifesciences's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eiko Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Eiko Lifesciences (BOM:540204) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹78.58, compared to a current price of ₹49.72 — trading 36.7% below its estimated fair value. The current Research & Development is ₹0.0 Mil. Eiko Lifesciences' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Eiko Lifesciences (BOM:540204), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eiko Lifesciences (BOM:540204) Overvalued in 2026?

Based on GuruFocus' analysis, Eiko Lifesciences stock appears to be undervalued. The current stock price of ₹49.72 is trading 36.7% below its estimated GF Value™ of ₹78.58. GuruFocus considers Eiko Lifesciences to be Significantly Undervalued.

Key valuation signals for BOM:540204:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹78.58 vs. price of ₹49.72 (36.7% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the BOM:540204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eiko Lifesciences Business Description

Address 604, Centrum, Wagle Estate, Opposite TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane, MH, IND, 400604
Eiko Lifesciences Ltd is a manufacturer, supplier, and exporter of specialty chemicals, fine chemicals, and pharma intermediates.. The company's segment includes Agrochemicals, Oleo Chemicals, Pharmaceuticals, Food Additives, clinical research, development, and Logistics. Geographically, the company generates the majority of its revenue from the Domestic market.
78GF Score

Get the complete analysis for BOM:540204

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹49.72
Price
₹78.58
GF Value